Related Experiment Video

Updated: Apr 27, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.0K

Conditional survival of heart failure patients after coronary artery bypass grafting

Jimmy T Efird1, Wesley T O'Neal, Gerard A Camargo

  • 1aEast Carolina Heart Institute, Department of Cardiovascular Sciences, Brody School of Medicine, East Carolina University bCenter for Health Disparities, Brody School of Medicine, East Carolina University, Greenville cDepartment of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina dDepartment of General Surgery, University of Virginia School of Medicine, Charlottesville, Virginia eDepartment of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Journal of Cardiovascular Medicine (Hagerstown, Md.)
|July 2, 2014
PubMed

Insights

Conditional survival estimates are higher than traditional survival rates for heart failure patients after coronary artery bypass grafting (CABG). This offers a more accurate long-term outlook for patient care.

Area of Science:

  • Cardiovascular Surgery
  • Heart Failure Research
  • Survival Analysis

Background:

  • Conditional survival estimates offer a refined prognosis for patients.
  • Traditional survival metrics may not fully capture long-term outcomes in specific patient groups.

Purpose of the Study:

  • To estimate conditional survival in heart failure patients post-coronary artery bypass grafting (CABG).
  • To compare conditional survival with traditional survival estimates in this cohort.

Main Methods:

  • Analysis of heart failure patients with multivessel coronary artery disease undergoing first-time, isolated CABG (1992-2011).
  • Calculation of conditional survival estimates at 1, 5, and 10 years post-surgery, conditional on surviving 0.5 to 5 years.

Main Results:

  • Conditional survival estimates were consistently higher than traditional survival rates.
  • For 1-year survivors, the 1-year conditional survival was 95%, compared to an overall 2-year survival of 84%.
  • For 5-year survivors, the 5-year conditional survival was 54%, versus an overall 10-year survival of 36%.

Conclusions:

  • Conditional survival provides a more accurate long-term survival estimate for heart failure patients after CABG.
  • This data aids patients and physicians in managing long-term care decisions.
  • Conditional survival offers valuable insights beyond standard survival metrics.
Abstract

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.5K
Implantation of the Syncardia Total Artificial Heart16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

36.9K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
631
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
788
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
750
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
886
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801